Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-24

Clinical Trial Update: Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema [NA]

View source ↗

Summary

A pediatric study evaluating fabric made with Lyocell/Chitosan/Ceramide for mild-to-moderate atopic dermatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Atopic Dermatitis | NA | Status: WITHDRAWN